Objective: Mutations in ATP1A3, the gene that encodes the α3 subunit of the Na + /K + ATPase, are the primary cause of alternating hemiplegia of childhood (AHC). Correlations between different mutations and AHC severity were recently reported, with E815K identified in severe and D801N and G947R in milder cases. This study aims to explore the molecular pathological mechanisms in AHC and to identify functional correlates for mutations associated with different levels of disease severity. Methods: Human wild type ATP1A3, and E815K, D801N and G947R mutants were expressed in Xenopus laevis oocytes and Na + /K + ATPase function measured. Structural homology models of the human α3 subunit containing AHC mutations were created.
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Results:
The AHC mutations examined all showed similar levels of reduction in forward cycling. Wild type forward cycling was reduced by coexpression with any mutant, indicating dominant negative interactions. Proton transport was measured and found to be selectively impaired only in E815K. Homology modeling showed that D801 and G947 lie within or near known cation binding sites while E815 is more distal. Despite its effect on proton transport, E815K was also distant from the proposed proton transport route. Interpretation: Loss of forward cycling and dominant negativity are common and likely necessary pathomechanisms for AHC. In addition, loss of proton transport correlated with severity of AHC. D801N and G947R are likely to directly disrupt normal Na
Introduction
Alternating hemiplegia of childhood (AHC) is a neurological disorder characterized by repeated attacks of paralysis on one or both sides of the body beginning before 18 months of age. There is a pressing need for effective AHC treatment. Flunarizine, a non-selective calcium channel blocker, is a widely prescribed drug for AHC. Unfortunately, flunarizine only provides symptomatic relief and its efficacy varies between patients (Mikati et al., 2000; Neville and Ninan, 2007; Sweney et al., 2009) . The development of AHC therapeutics has been hindered by its complex clinical presentation. There is a well recognized clinical heterogeneity in AHC, where some patients have longer or more frequent hemiplegic attacks in addition to greater extent of cognitive dysfunction and presence of co-morbidities such as seizure and respiratory complications. In contrast, some patients have relatively mild developmental delay and with few or no co-morbidities (Mikati et al., 2000; Sasaki et al., 2014; Yang et al., 2014) .
Sequencing studies identified mutations in the gene, ATP1A3, as a primary cause of AHC (Heinzen et al., 2012; Ishii et al., 2013; Rosewich et al., 2012) . Three recurring mutations within the gene account for~60% of all AHC cases, D801N, E815K, and G947R. Furthermore, genotype-phenotype analysis revealed that these mutations correlated with clinical severity. In general, patients with D801N or G947R have better clinical outcomes than patients with E815K (Sasaki Neurobiology of Disease 77 (2015) 88-93 
